Literature DB >> 7910579

Pulsed-field gel electrophoresis of the D4F104S1 locus reveals the size and the parental origin of the facioscapulohumeral muscular dystrophy (FSHD)-associated deletions.

C Wijmenga1, J C van Deutekom, J E Hewitt, G W Padberg, G J van Ommen, M H Hofker, R R Frants.   

Abstract

Recently, probe p13E-11 (D4F104S1) was shown to identify de novo DNA rearrangements, which are associated with the development of facioscapulohumeral muscular dystrophy (FSHD). These rearrangements are likely to become instrumental in cloning the FSHD gene itself. Analysis by pulsed-field gel electrophoresis demonstrates that p13E-11 recognizes two highly polymorphic loci, with HindIII restriction fragments ranging in size from about 30 to 320 kb. Haplotype analysis unambiguously assigned one of the two loci to chromosome 4q35. The detection of identical NotI or NruI fragments with both CEB8 (D4F35S1) and p13E-11 demonstrated that the DNA rearrangements are deletions that are restricted to the HindIII fragments detectable by p13E-11. In two cases, the sizes of the deletion could be established and were found to be 25 and 85 kb in length, respectively. So far, we have been able to define the parental origin of the mutation in seven different patients and have found that in five cases the maternal allele was involved.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910579     DOI: 10.1006/geno.1994.1006

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  15 in total

1.  Equal proportions of affected cells in muscle and blood of a mosaic carrier of facioscapulohumeral muscular dystrophy.

Authors:  Maria Manuela O Tonini; Richard J L F Lemmers; Rita C M Pavanello; Antonia M P Cerqueira; Rune R Frants; Silvere M van der Maarel; Mayana Zatz
Journal:  Hum Genet       Date:  2005-12-08       Impact factor: 4.132

2.  Diagnostic, predictive, and prenatal testing for facioscapulohumeral muscular dystrophy: diagnostic approach for sporadic and familial cases.

Authors:  E Bakker; M J Van der Wielen; E Voorhoeve; P F Ippel; G W Padberg; R R Frants; C Wijmenga
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

3.  Improved molecular diagnosis of facioscapulohumeral muscular dystrophy (FSHD): validation of the differential double digestion for FSHD.

Authors:  M Upadhyaya; J Maynard; M T Rogers; P W Lunt; P Jardine; D Ravine; P S Harper
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

4.  High proportion of new mutations and possible anticipation in Brazilian facioscapulohumeral muscular dystrophy families.

Authors:  M Zatz; S K Marie; M R Passos-Bueno; M Vainzof; S Campiotto; A Cerqueira; C Wijmenga; G Padberg; R Frants
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

Review 5.  Alternative splicing and muscular dystrophy.

Authors:  Mariaelena Pistoni; Claudia Ghigna; Davide Gabellini
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

6.  Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle.

Authors:  Dalila Laoudj-Chenivesse; Gilles Carnac; Catherine Bisbal; Gerald Hugon; Sandrine Bouillot; Claude Desnuelle; Yegor Vassetzky; Anne Fernandez
Journal:  J Mol Med (Berl)       Date:  2004-11-17       Impact factor: 4.599

7.  RNAPol-ChIP analysis of transcription from FSHD-linked tandem repeats and satellite DNA.

Authors:  Vassilios Alexiadis; Mary E Ballestas; Cecilia Sanchez; Sara Winokur; Vettaikorumakankav Vedanarayanan; Mary Warren; Melanie Ehrlich
Journal:  Biochim Biophys Acta       Date:  2006-11-22

8.  De novo facioscapulohumeral muscular dystrophy defined by DNA probe p13E-11 (D4F104S1).

Authors:  P E Jardine; M C Koch; P W Lunt; J Maynard; K D Bathke; P S Harper; M Upadhyaya
Journal:  Arch Dis Child       Date:  1994-09       Impact factor: 3.791

9.  Analysis of the organisation and localisation of the FSHD-associated tandem array in primates: implications for the origin and evolution of the 3.3 kb repeat family.

Authors:  L N Clark; U Koehler; D C Ward; J Wienberg; J E Hewitt
Journal:  Chromosoma       Date:  1996-09       Impact factor: 4.316

10.  Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects.

Authors:  Marietta Barro; Gilles Carnac; Sébastien Flavier; Jacques Mercier; Yegor Vassetzky; Dalila Laoudj-Chenivesse
Journal:  J Cell Mol Med       Date:  2008-05-24       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.